Year archive

Hyundai ADM Bio lnc. — 2026 filings

All 21 regulatory filings released by Hyundai ADM Bio lnc. (187660) in 2026, sourced directly from the official regulator.

21 Filings

2026 Period

2026 filings (21)

Filing	Released	Lang
[기재정정]증권신고서(지분증권) Capital/Financing Update	2026-05-27	Korean
[기재정정]주요사항보고서(유상증자결정) Share Issue/Capital Change	2026-05-27	Korean
분기보고서 (2026.03) Interim / Quarterly Report Q1 2026	2026-05-15	Korean
투자판단관련주요경영사항(임상시험계획변경승인신청) ((불응성/재발성 고형암 대상 펨브롤리주맙과 PenetriumTM 병용요법 1상 임상시험계획 변경승인 신청)) Regulatory Filings	2026-05-13	Korean
주요사항보고서(유상증자결정) Capital/Financing Update	2026-04-30	Korean
증권신고서(지분증권) Capital/Financing Update	2026-04-30	Korean
주식등의대량보유상황보고서(일반) Major Shareholding Notification	2026-03-26	Korean
[기재정정]단일판매ㆍ공급계약체결 Regulatory Filings	2026-03-17	Korean
주식등의대량보유상황보고서(일반) Major Shareholding Notification	2026-03-12	Korean
[기재정정]주식매수선택권부여에관한신고 Regulatory Filings	2026-03-10	Korean
정기주주총회결과 Declaration of Voting Results & Voting Rights Announcements	2026-03-06	Korean
상호변경안내 Regulatory Filings	2026-03-06	Korean
주식매수선택권부여에관한신고 Share Issue/Capital Change	2026-03-06	Korean
조회공시요구(현저한시황변동)에대한답변(미확정) Regulatory Filings	2026-02-20	Korean
[기재정정]주주총회소집공고 AGM Information	2026-02-20	Korean
주주총회소집결의 AGM Information	2026-02-19	Korean
주주총회소집공고 AGM Information	2026-02-19	Korean
조회공시요구(현저한시황변동) Regulatory Filings	2026-02-19	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2026-02-10	Korean
파생상품거래손실발생 Regulatory Filings	2026-01-22	Korean
매출액또는손익구조30%(대규모법인은15%)이상변동 Earnings Release FY 2025	2026-01-22	Korean